Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
about
The management of glaucoma and intraocular hypertension: current approaches and recent advancesMeta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension24-h Efficacy of Glaucoma Treatment OptionsThe effect on intraocular pressure of latanoprost once or four times dailyEffects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeabilityGlaucoma medical treatment: philosophy, principles and practice.The outcome of mitomycin C trabeculectomy and laser suture lysis depends on postoperative management.Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy.Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.Effect of previous argon laser trabeculoplasty on the ocular hypotensive action of latanoprost.Performing meta-analysis with incomplete statistical information in clinical trialsRecent advances in pharmacotherapy of glaucomaFirst-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressureMeta-analysis of randomized controlled trials comparing latanoprost with timolol in the treatment of Asian populations with chronic angle-closure glaucomaIncidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications.Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis.Efficacy of Garcinia kola 0.5% Aqueous Eye Drops in Patients with Primary Open-Angle Glaucoma or Ocular HypertensionComparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionThe influence of topical prostaglandin analogues in inflammation after selective laser trabeculoplasty treatment.Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines.Latanoprost-induced changes in rat intraocular pressure: direct or indirect?The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo.Clinical options for the reduction of elevated intraocular pressureEffect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study.Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure.Glaucoma management: relative value and place in therapy of available drug treatments.Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.A double masked comparison of the intraocular pressure reducing effect of latanoprost 0.005% and 0.001% administered once daily in open angle glaucoma and ocular hypertension.Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish LaA comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group.Emerging drugs for ophthalmic diseases.Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.Incidence of iris colour change in latanoprost treated eyes.Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamideA 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertensionRelation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucomaA comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom
P2860
Q22305849-49B4FC8A-3062-4D78-9A3A-579C53924EF0Q24672885-2DCE47CA-011C-4591-9B14-407E1693E9E2Q26766594-885EB900-0CF4-40B5-AAC5-F967743332F3Q28360261-E547BD56-5BB1-4A4B-9B07-D352646D7283Q28379588-1ADCD000-07DA-40F6-B859-A84C8EAC65C8Q30327343-8E20F646-FFA1-4C7F-8BB4-1DFA6929EFD3Q30827359-7B0C1240-9D5D-4DDA-8D08-C97CB97B5626Q31075828-A903999A-8F4D-4ADE-A596-34D6909981EBQ31890726-FAFD06A5-CF51-41F1-BB55-CD2EF035DCC4Q33231747-1B0D72C0-234A-417E-AADE-0AEA36756296Q33360471-A7B2ED5E-C051-41DB-B5CF-7FBC0399682BQ33521178-9E796505-087B-42E7-BE9C-FF851FCBD471Q33534044-DA5A22B0-FA3A-4C8D-8241-771288CB35A2Q33590856-01E2A02C-0FBF-48DB-AD4D-8BF906326A9FQ33819802-60CE61CF-8822-45BA-BCA1-4F66EAFF8E86Q33865232-D08CFE5E-5578-4588-915C-E45148E0504EQ33892713-30851591-90EC-4C39-BFA1-A3DC8FA3697CQ33996251-F96C9D4F-5CF4-4AF7-9995-12AFB66B8F2FQ34043309-C6481F5C-BB10-4EC9-BDAD-D9310F668894Q34075906-3E85F0D9-0DC8-4DD2-930D-916E72C6B173Q34078656-EFD8FBB1-406A-4157-9C56-7DFB0B156550Q34309976-F43C544E-C026-4B12-ADFF-68B50FB7B18AQ34511054-5C06D07A-F87C-455C-9BB9-C9E7979C02FBQ34708267-0732D4B9-F16E-435F-8237-2340419DAF32Q34719257-1FDEC66A-11E5-4D49-B458-9B59D8D51276Q34996623-51B2A9CE-8041-4342-942A-95D90BED1BCBQ35079342-151368A6-D58A-4A84-90A5-17156AC01EE0Q35237431-93DEF88F-0D09-424D-A843-420CAC32BB18Q35298399-03CF5E03-8DD1-4885-8A0E-2DD8B0A6CE86Q35313371-88FD3A79-116F-4AA5-BFBB-2408F5F29C83Q35314724-47976AE2-0461-4276-8C94-2DB135B6A607Q35581180-5FECB076-1B50-4772-BFBC-D883255731CEQ35589367-8E13A991-2135-450A-B0F8-F1BC8C9ADC39Q35590132-99387BA9-4F32-4B3F-B1CC-5906D12F81E2Q35590963-19E863C9-68B4-420B-8C7A-28F4747C24A7Q35591747-A64E9494-010F-4B3F-84BC-452719E7FF8EQ35592027-D680F678-0D02-48E1-AEDE-48036558FFC7Q35592180-E57581C9-A1C2-4AB7-A5A8-AB81B85BAB48Q35592524-12998B15-43BE-4AF5-804A-F285D95C8338Q35592544-441E5F76-B03C-4142-A429-0396BEE7F5C5
P2860
Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Comparison of latanoprost and ...... tates Latanoprost Study Group.
@en
Comparison of latanoprost and ...... tates Latanoprost Study Group.
@nl
type
label
Comparison of latanoprost and ...... tates Latanoprost Study Group.
@en
Comparison of latanoprost and ...... tates Latanoprost Study Group.
@nl
prefLabel
Comparison of latanoprost and ...... tates Latanoprost Study Group.
@en
Comparison of latanoprost and ...... tates Latanoprost Study Group.
@nl
P1433
P1476
Comparison of latanoprost and ...... tates Latanoprost Study Group.
@en
P2093
P304
P356
10.1016/S0161-6420(96)30749-5
P577
1996-01-01T00:00:00Z